Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Amedisys, Inc. (NASDAQ: AMED).

Full DD Report for AMED

You must become a subscriber to view this report.


Recent News from (NASDAQ: AMED)

Addus HomeCare: A Tiny But Growing Share Of A $60 Billion Market
Thesis Addus ( ADUS ) reported a solid Q3-18, with revenue growth of 26.7%. The bulk of the growth came from an acquisition. Organic growth was up 3.7%, in line with the company's stated goal of achieving a perpetual organic revenue growth rate of 3-5%. Addus is a leading provider of perso...
Source: SeekingAlpha
Date: November, 20 2018 07:04
Today's Research Reports on Stocks to Watch: Electro Scientific Industries and Amedisys
NEW YORK, NY / ACCESSWIRE / October 31, 2018 / Shares of Electro Scientific Industries was soaring on Tuesday as the company reported second quarter results and announced that it would be acquired by MKS Instruments for $1 billion. Shares of Amedisys was also in the green after reporting sol...
Source: ACCESSWIRE IA
Date: October, 31 2018 08:00
Amedisys, Inc. (AMED) CEO Paul Kusserow on Q3 2018 Results - Earnings Call Transcript
Amedisys, Inc. (AMED) Q3 2018 Results Conference Call October 30, 2018 11:00 AM ET Executives Nick Muscato - Vice President of Strategic Finance Paul Kusserow - President and Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer D...
Source: SeekingAlpha
Date: October, 30 2018 17:18
AMEDISYS Inc 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by AMEDISYS Inc in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 30 2018 14:32
Amedisys  beats by $0.18, beats on revenue
Amedisys  (NASDAQ: AMED ): Q3 Non-GAAP EPS of $0.95 beats by $0.18 ; GAAP EPS of $0.96 beats by $0.20 . More news on: AMEDISYS Inc, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 29 2018 17:04
Amedisys Reports Third Quarter 2018 Financial Results and Updates 2018 Guidance
BATON ROUGE, La., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month period ended September 30, 2018. Three Month Periods Ended September 30, 2018 and 2017 Net service revenue increased $43.6 ...
Source: GlobeNewswire
Date: October, 29 2018 17:00
New Research: Key Drivers of Growth for Pepsico, SBA Communications, Cavco Industries, Concho Resources, Enstar Group, and Amedisys - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Pepsico, Inc. (NASDAQ:PEP), SBA Communications Corporation (NASDAQ:SBAC),...
Source: GlobeNewswire
Date: October, 19 2018 07:50
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: "AMED"), announced today that it will report results for the third quarter ended September 30, 2018 after the market closes on October 29, 2018.  The Company will host an investor conference call to discuss the...
Source: GlobeNewswire
Date: October, 16 2018 12:00
Amedisys (AMED) To Acquire Compassionate Care Hospice - Slideshow
The following slide deck was published by AMEDISYS Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: October, 10 2018 14:13
Amedisys Signs Definitive Agreement to Acquire Compassionate Care Hospice
BATON ROUGE, La., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care company, announced today that it has signed a definitive agreement to acquire Compassionate Care Hospice (“CCH”), a nat...
Source: GlobeNewswire
Date: October, 10 2018 07:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-08122.92121.95126.27121.62286,956
2018-05-1772.7774.4274.4971.34265,745
2017-02-0245.4745.6046.0645.29150,326
2017-02-0145.6345.5746.5545.19307,721
2017-01-3144.2645.8246.5143.48313,875

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1436,358193,92918.7481Cover
2018-12-1333,74850,73566.5182Short
2018-12-1284,233159,20352.9092Short
2018-12-1150,067190,03026.3469Cover
2018-12-1032,596129,75925.1204Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AMED.


About Amedisys, Inc. (NASDAQ: AMED)

Logo for Amedisys, Inc. (NASDAQ: AMED)

Not available

 

Contact Information

 

 

Current Management

  • William F. Borne / CEO
  • Promod K. Seth / COO
  • Mitchel G. Morel / CFO

Current Share Structure

  • Market Cap: $1,933,543,331 - 05/14/2018
  • Issue and Outstanding: 26,993,485 - 10/23/2008

 


Recent Filings from (NASDAQ: AMED)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 25 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 24 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (NASDAQ: AMED)

Daily Technical Chart for (NASDAQ: AMED)


Stay tuned for daily updates and more on (NASDAQ: AMED)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AMED)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AMED is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AMED and does not buy, sell, or trade any shares of AMED. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/